XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Net income $ 2,532 $ 1,287 $ 6,068 $ 22,609  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Change in fair value of contingent consideration     (46) (384)  
Change in fair value of Contract Consideration Convertible Notes Payable 0 0 0 (29,969)  
Amortization of convertible note issuance costs     0 83  
Paid-in-kind interest expense     0 2,284  
Amortization of contract assets     4,341 3,665  
Depreciation 220 181 662 530  
Amortization of asset-based loan origination costs     243 36  
Provision for credit losses, net of recoveries     121 97 $ 138
Provision for excess and obsolete inventory     626 626  
Gain on sale of property and equipment 0 (38) (34) (38)  
Non-cash lease expense     1,661 2,316  
Stock compensation expense     915 (565)  
Deferred income tax expense     233 50  
Paycheck protection plan loan forgiveness 0 0 0 (4,522)  
Changes in current assets and liabilities:          
Accounts receivable     1,346 3,472  
Accounts receivable, related party     (12,495) (2,082)  
Inventories     (532) (776)  
Other assets     849 (863)  
Accounts payable     5,690 60  
Accrued liabilities     (1,730) (3,179)  
Operating lease liabilities     (2,002) (2,636)  
Income taxes payable     9 (54)  
Interest payable     0 (8)  
Net cash provided by (used in) operating activities     5,925 (9,248)  
Cash flows from investing activities:          
Capital expenditures     (491) (593)  
Proceeds from sale of assets     34 68  
Net cash used in investing activities     (457) (525)  
Cash flows from financing activities:          
Payment for forfeited stock options     0 (617)  
Payments on long term debt     (135) (104)  
Proceeds from asset-based loan     122,600 27,750  
Payments on asset-based loan     (128,666) (24,380)  
Payment of asset-based loan origination costs     (164) (502)  
Payments to tax authorities for shares withheld from employees     (30) (246)  
Proceeds from issuance of stock     88 48  
Payments for finance leases     (22) (24)  
Net cash (used in) provided by financing activities     (6,329) 1,925  
Effect of changes in exchange rates on cash and cash equivalents     6 13  
Net change in cash and cash equivalents and restricted cash     (855) (7,835)  
Cash and cash equivalents at the beginning of period     5,851 12,290 12,290
Restricted cash at the beginning of period     102 100 100
Cash and cash equivalents and restricted cash at beginning of period     5,953 12,390 12,390
Cash and cash equivalents at end of period 4,997 4,453 4,997 4,453 5,851
Restricted cash at the end of period 101 102 101 102 102
Cash and cash equivalents and restricted cash at end of period $ 5,098 $ 4,555 $ 5,098 $ 4,555 $ 5,953